Which 503B outsourcing facilities had FDA inspections classified Official Action Indicated?
Which 503B outsourcing facilities had FDA inspections classified Official Action Indicated (OAI)?
38 of the 100 facilities on FDA’s registered 503B outsourcing facility list (updated Nov 6, 2026) have at least one FDA inspection classified Official Action Indicated (OAI) in the FDA Data Dashboard, checked Nov 15, 2026, 87 OAI inspections in all. 48 of the 100 facilities were matched to an inspected site in the dashboard by exact name, city and state; the other 52 could not be matched, so their inspection classifications are not counted here. The dashboard covers drug inspections ending Oct 1, 2008 to Oct 23, 2026, and an OAI classification may come from an inspection at that site before it registered as an outsourcing facility.
OAI means FDA recommended regulatory or administrative action after the inspection. It is FDA’s classification, not a finding by this site, and the dashboard does not say what the action was. Facility pages list each inspection with its date and classification.
Facilities with an OAI inspection
| Pine Pharmaceuticals, LLC | Tonawanda, NY | 5 | Nov 14, 2025 | 7 | 6 |
| AnazaoHealth Corporation | Las Vegas, NV | 5 | Aug 8, 2025 | 5 | 7 |
| US Specialty Formulations LLC | Allentown, PA | 5 | Jul 2, 2024 | 7 | 6 |
| Central Admixture Pharmacy Services, Inc. | Allentown, PA | 4 | Sep 5, 2025 | 5 | 6 |
| RC Outsourcing, LLC | Lowellville, OH | 4 | Aug 28, 2025 | 6 | 9 |
| Fagron Compounding Services dba Fagron Sterile Services | Wichita, KS | 4 | Aug 8, 2025 | 5 | 5 |
| Apollo Care | Columbia, MO | 4 | Mar 27, 2025 | 4 | 4 |
| Qualgen LLC | Edmond, OK | 4 | Jun 15, 2021 | 6 | 5 |
| Delta Pharma, Inc. | Ripley, MS | 4 | Feb 23, 2017 | 6 | 7 |
| Quva Pharma, Inc. | Bloomsbury, NJ | 3 | Apr 4, 2025 | 4 | 4 |
| Imprimis NJOF, LLC | Ledgewood, NJ | 3 | Apr 3, 2024 | 3 | 4 |
| IntegraDose Compounding Services, LLC | Shoreview, MN | 3 | Mar 1, 2024 | 4 | 5 |
| Park Avenue Compounding | St. Louis, MO | 3 | Feb 8, 2024 | 5 | 6 |
| Ajenat Pharmaceuticals, LLC | Largo, FL | 3 | Jan 7, 2013 | 15 | 0 |
| Staska Pharmaceuticals, Inc. | Bennet, NE | 2 | Feb 20, 2026 | 2 | 2 |
| ProRx LLC | Exton, PA | 2 | Sep 19, 2025 | 2 | 2 |
| Central Admixture Pharmacy Services | Phoenix, AZ | 2 | Sep 5, 2025 | 4 | 3 |
| BSO LLC | Lakewood, CO | 2 | Jul 16, 2025 | 5 | 4 |
| Medi-Fare Drug | Blacksburg, SC | 2 | Jun 6, 2025 | 6 | 5 |
| Stokes Healthcare Inc., dba Epicur Pharma | Mt. Laurel, NJ | 2 | May 23, 2025 | 4 | 5 |
| McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions | Santa Ana, CA | 2 | Apr 28, 2025 | 11 | 0 |
| Farmakeio Outsourcing LLC | Southlake, TX | 2 | Jun 10, 2022 | 2 | 3 |
| Brookfield Medical/Surgical Supply, Inc. | Brookfield, CT | 2 | Apr 18, 2017 | 4 | 8 |
| Fresenius Kabi Compounding LLC dba Fagron Sterile Services | Canton, MA | 1 | Nov 5, 2025 | 3 | 2 |
| BSO LLC | Golden, CO | 1 | Jun 27, 2025 | 1 | 1 |
| MedisourceRx | Los Alamitos, CA | 1 | Jun 10, 2025 | 3 | 4 |
| Tailstorm Health Inc. | Chandler, AZ | 1 | May 23, 2025 | 2 | 3 |
| Apothecary Pharma, LLC | Cary, NC | 1 | May 15, 2025 | 1 | 1 |
| PQ Pharmacy LLC | Brooksville, FL | 1 | Apr 4, 2025 | 2 | 3 |
| Wells Pharma of Houston, LLC | Houston, TX | 1 | Mar 28, 2025 | 3 | 4 |
| Turbare Manufacturing | Conway, AR | 1 | Jan 24, 2025 | 1 | 2 |
| OSRX, Inc. | Missoula, MT | 1 | Oct 25, 2024 | 3 | 4 |
| Annovex Pharma, Inc. | Lorton, VA | 1 | Sep 6, 2024 | 1 | 2 |
| Nubratori, Inc. | Torrance, CA | 1 | Jul 26, 2024 | 5 | 3 |
| Vitae Enim Vitae Scientific, Inc. | San Diego, CA | 1 | Sep 22, 2021 | 3 | 0 |
| Quva Pharma, Inc. | Sugar Land, TX | 1 | Apr 23, 2019 | 5 | 7 |
| Leesar Inc. | Fort Myers, FL | 1 | Jul 12, 2017 | 5 | 5 |
| Wells Pharmacy, Inc. | Dyersburg, TN | 1 | Oct 20, 2016 | 4 | 5 |
Matched facilities with no OAI inspection in the dashboard
These 10 facilities match an inspected site in the dashboard, and none of that site’s inspections listed there, ending Oct 1, 2008 to Oct 23, 2026, is classified OAI as of Nov 15, 2026.
- BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy, Temple Terrace, FL: 2 classified inspections, latest ended Jun 2, 2023, VAI
- BPI Labs LLC, Largo, FL: 2 classified inspections, latest ended Apr 23, 2025, VAI
- Denver Solutions, LLC, dba Leiters Health, Englewood, CO: 5 classified inspections, latest ended Dec 11, 2025, VAI
- F.H. Investments, Inc., Birmingham, AL: 2 classified inspections, latest ended Nov 8, 2024, VAI
- Mark Cuban Cost Plus Manufacturing and Compounding, LLC, Dallas, TX: 1 classified inspection, latest ended Sep 6, 2024, VAI
- Molecular PharmaGroup, New Providence, NJ: 2 classified inspections, latest ended Aug 11, 2025, VAI
- OurPharma LLC, Fayetteville, AR: 2 classified inspections, latest ended Sep 27, 2024, VAI
- STAQ Pharma of Ohio, LLC, Columbus, OH: 2 classified inspections, latest ended May 16, 2025, VAI
- STAQ Pharma, Inc., Denver, CO: 3 classified inspections, latest ended Feb 10, 2025, VAI
- Wesley Pharmaceuticals, Orlando, FL: 1 classified inspection, latest ended Mar 16, 2026, NAI
Facilities not matched to the dashboard
No inspected site under the same name and city was found in the dashboard for these 52 facilities. FDA’s 503B list gives their last inspection as shown; the dashboard may list them under another legal name.
- 503B Outsourcing Facility One, LLC, West Palm Beach, FL: last inspection on FDA’s 503B list: Not yet inspected
- Apertus Compounding, LLC, Maryland Heights, MO: last inspection on FDA’s 503B list: Not yet inspected
- Apocus, Inc., San Antonio, TX: last inspection on FDA’s 503B list: Not yet inspected
- Arc Compounding Pharmacy, LLC, Waco, TX: last inspection on FDA’s 503B list: Not yet inspected
- Aspire Compounding Pharmacy, Sugar Land, TX: last inspection on FDA’s 503B list: Not yet inspected
- Assure Infusions, Inc., Bartow, FL: last inspection on FDA’s 503B list: Sep 17, 2026
- Atilar Pharma Corporation, Houston, TX: last inspection on FDA’s 503B list: Not yet inspected
- Aveva Drug Delivery Systems, Inc, Tamarac, FL: last inspection on FDA’s 503B list: Not yet inspected
- Bennett Pharmaceuticals of America LLC, Hudson, WI: last inspection on FDA’s 503B list: Not yet inspected
- Bespoke Pharmaceutical, LLC, Las Vegas, NV: last inspection on FDA’s 503B list: Not yet inspected
- Bravado Pharmaceuticals, LLC, Lutz, FL: last inspection on FDA’s 503B list: Not yet inspected
- Denver Solutions, LLC, dba Leiters Health, Buena, NJ: last inspection on FDA’s 503B list: Not yet inspected
- Eagle Pharma, Birmingham, AL: last inspection on FDA’s 503B list: Sep 29, 2026
- Empower Clinic Services New Jersey, East Windsor, NJ: last inspection on FDA’s 503B list: Not yet Inspected
- Empower Pharma, Houston, TX: last inspection on FDA’s 503B list: Nov 14, 2025
- Galaxy Pharmaceuticals, LLC, Albany, NY: last inspection on FDA’s 503B list: Not yet inspected
- GenoGenix LLC, Raton, FL: last inspection on FDA’s 503B list: Jul 18, 2025
- GFC Pharma, LLC, Westminster, MD: last inspection on FDA’s 503B list: Not yet inspected
- Hyalo Technologies Limited Liability Company, Somerset, NJ: last inspection on FDA’s 503B list: Not yet inspected
- Hybrid Pharma, LLC, Deerfield Beach, CA: last inspection on FDA’s 503B list: Aug 27, 2026
- Maxhealth Group, LLC dba New Life Rx, Dallas, TX: last inspection on FDA’s 503B list: Not yet inspected
- Medicinal Sciences Ltd. Co., Heath, TX: last inspection on FDA’s 503B list: Not yet inspected
- Navasha Pharma Labs Limited, Bensalem, PA: last inspection on FDA’s 503B list: Not yet inspected
- Navinta III Inc., Boca Raton, FL: last inspection on FDA’s 503B list: Not yet inspected
- Nephron Sterile Compounding Center, LLC (NSCC), West Columbia, SC: last inspection on FDA’s 503B list: Aug 22, 2025
- Nexgen Formulations, Folcroft, PA: last inspection on FDA’s 503B list: Not yet inspected
- Nivagen Pharmaceuticals, LLC, Sacramento, CA: last inspection on FDA’s 503B list: Not yet inspected
- NLRx, LLC, Cookeville, TN: last inspection on FDA’s 503B list: Not yet inspected
- Ocyon Bio PR, LLC, Aguadilla, PR: last inspection on FDA’s 503B list: Not yet inspected
- Olympia Pharmaceuticals, Orlando, FL: last inspection on FDA’s 503B list: Sep 3, 2026
- Olyx Pharma, Schertz, TX: last inspection on FDA’s 503B list: Not yet inspected
- Orion Specialty Labs, LLC, , : last inspection on FDA’s 503B list: Not yet inspected
- PGRrx LLC, Exton, PA: last inspection on FDA’s 503B list: Not yet inspected
- Quantum Pharmaceuticals, LLC, Mounds, OK: last inspection on FDA’s 503B list: Not yet inspected
- Rapha Pharmaceuticals, lnc., Las Vegas, NV: last inspection on FDA’s 503B list: Not yet inspected
- Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop, Irving, TX: last inspection on FDA’s 503B list: Sep 8, 2026
- Sankav Pharmaceuticals, LLC, Hackettstown, NJ: last inspection on FDA’s 503B list: Not yet inspected
- SCA Pharmaceuticals, Little Rock, AR: last inspection on FDA’s 503B list: Oct 30, 2025
- SCA Pharmaceuticals, Windsor, CT: last inspection on FDA’s 503B list: Mar 13, 2026
- Signature Rx, Delray Beach, FL: last inspection on FDA’s 503B list: Not yet inspected
- Simple RX Solutions, P.C., Lewisburg, TN: last inspection on FDA’s 503B list: Not yet inspected
- SKNV formerly registered as Sincerus Florida, LLC, Pompano Beach, FL: last inspection on FDA’s 503B list: May 29, 2026
- Strive Outsourcing LLC, Alachua, FL: last inspection on FDA’s 503B list: Not yet inspected
- University of Tennessee, Memphis, TN: last inspection on FDA’s 503B list: Not yet inspected
- VitalRx Pharmacy, LLC, Houston, TX: last inspection on FDA’s 503B list: Not yet inspected
- WeCare Pharmaceutical Corp dba WeCare Pharmaceuticals, Chantilly, VA: last inspection on FDA’s 503B list: Not yet inspected
- Wedgewood Connect Ohio, LLC, Albany, OH: last inspection on FDA’s 503B list: Not yet inspected
- Wedgewood Connect, LLC, formerly registered as Leiter's Compounding, San Jose, CA: last inspection on FDA’s 503B list: Jul 3, 2025
- White Label Pharmacy dba Nova Pharmacy, Katy, TX: last inspection on FDA’s 503B list: Not yet inspected
- Wilcrest Pharmaceuticals, Inc., Houston, TX: last inspection on FDA’s 503B list: Not yet inspected
- Willowbend Pharma Select, LLC, Houston, TX: last inspection on FDA’s 503B list: Not yet inspected
- Xseer Pharmaceuticals, Inc., Los Angeles, CA: last inspection on FDA’s 503B list: Not yet inspected
Common questions
What does Official Action Indicated mean?
FDA classifies each inspection when it closes. Official Action Indicated (OAI) means FDA recommended regulatory or administrative action, such as a warning letter. Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA did not recommend action, and No Action Indicated (NAI) means none were found or they did not justify action.
How are facilities matched to the dashboard?
FDA’s 503B list gives no FEI number, so a facility is matched only when the dashboard names an inspected site with the same normalized name, the same city and the same state. Inspections and published Form 483s are then read by that site’s FEI number.
Does an OAI classification mean a facility is closed or barred?
No. It records FDA’s classification of one inspection. The facility pages list FDA’s letters and other actions from FDA’s own compounding actions page, where they exist.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: Compounding: Inspections, Recalls, and other Actions
Records last pulled Nov 15, 2026. Every entry links to the original public record.